Skip to content

NMN for Ischemic Heart Disease: What the Evidence Actually Shows

Category: cardiovascular | ICD-10: I25.9 | Evidence tier: mouse-only

What is Ischemic Heart Disease?

Ischemic heart disease is reduced blood flow to the heart muscle, usually from coronary atherosclerosis. It causes angina and heart attack and is the leading cause of death in Malaysia.

NMN relevance: the published evidence

Pre-clinical work shows NMN reduces ischaemia-reperfusion injury in rodent hearts. Translation to human ischemic heart disease has not been tested in any completed RCT. Patients should rely on guideline therapy (antiplatelets, statins, beta-blockers, revascularisation).

Questions to ask before supplementing

No dose validated for ischemic heart disease.

Contraindications and red flags

Continue all cardiology medications. Discuss any supplement before cardiac procedures.

Bottom line for Malaysian patients

NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have ischemic heart disease, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.

Related conditions

Cited references